Loading...

Camurus AB (publ)

CAMRFPNK
Healthcare
Biotechnology
$71.00
$0.00(0.00%)

Camurus AB (publ) (CAMRF) Stock Overview

Explore Camurus AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 75.3/100

Key Financials

Market Cap4.2B
P/E Ratio72.63
EPS (TTM)$1.26
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Week$53.29
1 Month$218.47
3 Months$59.57
1 Year Target$67.15

CAMRF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Camurus AB (publ) (CAMRF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $67.15.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 72.63 and a market capitalization of 4.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;